Focus on nitrosamines: containment and filter solutions for maximum pharmaceutical safety
Nitrosamines have been a key quality and safety issue in the pharmaceutical industry for several years. The discovery of nitrosamine-containing impurities in active ingredients and medicines has led to stricter regulatory requirements worldwide. Pharmaceutical...
Bayer Solida-1
Solida-1 is more than just a factory – it is a scalable production model that could serve as a model for future pharmaceutical sites. Thanks to the modular architecture and the spine concept, the plant can be adapted to new requirements at any time.
Retrofit containment solutions for existing systems: Optimize safety and compliance economically
Pharmaceutical and fine chemical companies must regularly adapt their production environments to new regulations.Stricter GMP requirements, the increased use of highly potent active ingredients (HPAPI) and stricter explosion protection requirements pose challenges for...
